Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014
- PMID: 26858376
- DOI: 10.1377/hlthaff.2015.1080
Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014
Abstract
In the 2012 Global Vaccine Action Plan, development assistance partners committed to providing sustainable financing for vaccines and expanding vaccination coverage to all children in low- and middle-income countries by 2020. To assess progress toward these goals, the Institute for Health Metrics and Evaluation produced estimates of development assistance for vaccinations. These estimates reveal major increases in the assistance provided since 2000. In 2014, $3.6 billion in development assistance for vaccinations was provided for low- and middle-income countries, up from $822 million in 2000. The funding increase was driven predominantly by the establishment of Gavi, the Vaccine Alliance, supported by the Bill & Melinda Gates Foundation and the governments of the United States and United Kingdom. Despite stagnation in total development assistance for health from donors from 2010 onward, development assistance for vaccination has continued to grow.
Keywords: Development assistance for health; Health Aid; Vaccines.
Project HOPE—The People-to-People Health Foundation, Inc.
Similar articles
-
Costs of vaccine programs across 94 low- and middle-income countries.Vaccine. 2015 May 7;33 Suppl 1:A99-108. doi: 10.1016/j.vaccine.2014.12.037. Vaccine. 2015. PMID: 25919184
-
Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.Lancet. 2021 Nov 20;398(10314):1875-1893. doi: 10.1016/S0140-6736(21)01591-9. Epub 2021 Nov 4. Lancet. 2021. PMID: 34742369 Free PMC article.
-
Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.Health Aff (Millwood). 2016 Feb;35(2):250-8. doi: 10.1377/hlthaff.2015.1079. Health Aff (Millwood). 2016. PMID: 26858377
-
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.Lancet. 2021 Oct 9;398(10308):1317-1343. doi: 10.1016/S0140-6736(21)01258-7. Epub 2021 Sep 22. Lancet. 2021. PMID: 34562388 Free PMC article. Review.
-
Innovative financing instruments for global health 2002-15: a systematic analysis.Lancet Glob Health. 2017 Jul;5(7):e720-e726. doi: 10.1016/S2214-109X(17)30198-5. Lancet Glob Health. 2017. PMID: 28619230 Review.
Cited by
-
Funding gap for immunization across 94 low- and middle-income countries.Vaccine. 2016 Dec 7;34(50):6408-6416. doi: 10.1016/j.vaccine.2016.09.036. Epub 2016 Oct 28. Vaccine. 2016. PMID: 28029541 Free PMC article.
-
Health financing at district level in Malawi: an analysis of the distribution of funds at two points in time.Health Policy Plan. 2018 Jan 1;33(1):59-69. doi: 10.1093/heapol/czx130. Health Policy Plan. 2018. PMID: 29088357 Free PMC article.
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0. Lancet. 2017. PMID: 28919115 Free PMC article.
-
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9. Lancet. 2017. PMID: 28919116 Free PMC article.
-
Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study.Lancet. 2019 May 4;393(10183):1843-1855. doi: 10.1016/S0140-6736(19)30226-0. Epub 2019 Apr 5. Lancet. 2019. PMID: 30961907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical